Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 496 AL 510

TRanscranial AlterNating current stimulation FOR patients with mild Alzheimer's Disease (TRANSFORM-AD): a randomized controlled clinical trial

Tang Y, Xing Y, Sun L, Wang Z, Wang C, Yang K, Zhu W, Shi X, Xie B, Yin Y, Mi Y, Wei T, Tong R, Qiao Y, Yan S, Wei P, Yang Y, Shan Y, Zhang X, Jia J, Teipel SJ, Howard R, Lu J, Li C, Zhao G.

Alzheimers Res Ther. 2024 Sep 12;16(1):203. doi: 10.1186/s13195-024-01570-0.

Alzheimer Disease: Treatment of Cognitive and Functional Symptoms

Jaqua EE, Tran MN, Hanna M.

Am Fam Physician. 2024 Sep;110(3):281-293.

AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling

Kale M, Wankhede N, Pawar R, Ballal S, Kumawat R, Goswami M, Khalid M, Taksande B, Upaganlawar A, Umekar M, Kopalli SR, Koppula S.

Ageing Res Rev. 2024 Nov;101:102497. doi: 10.1016/j.arr.2024.102497. Epub 2024 Sep 16.

Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2

Tumati S, Herrmann N, Perin J, Rosenberg PB, Lerner AJ, Mintzer J, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Shade D, Lanctôt KL.

Int Psychogeriatr. 2024 Dec;36(12):1232-1244. doi: 10.1017/S1041610224000711. Epub 2024 Sep 19.

Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy

Belder CRS, Boche D, Nicoll JAR, Jaunmuktane Z, Zetterberg H, Schott JM, Barkhof F, Fox NC.

Lancet Neurol. 2024 Oct;23(10):1025-1034. doi: 10.1016/S1474-4422(24)00335-1.

Prescription of Nonpharmacologic Interventions in Memory Clinics: Data from the Clinical Pathway for Alzheimer's Disease in China (CPAD) Study

Cai X, Zhang Y, Shi C, Wong GHY, Luo H, Wang H.

J Am Med Dir Assoc. 2024 Dec;25(12):105273. doi: 10.1016/j.jamda.2024.105273. Epub 2024 Sep 19.

Unveiling the theranostic potential of SPIONs in Alzheimer's disease management

Aminyavari S, Afshari AR, Ahmadi SS, Kesharwani P, Sanati M, Sahebkar A.

J Psychiatr Res. 2024 Nov;179:244-256. doi: 10.1016/j.jpsychires.2024.09.022. Epub 2024 Sep 20.

Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan

Sato K, Niimi Y, Ihara R, Iwata A, Suzuki K, Nemoto K, Arai T, Higashi S, Igarashi A, Kasuga K, Awata S, Iwatsubo T.

Alzheimers Res Ther. 2024 Oct 3;16(1):205. doi: 10.1186/s13195-024-01568-8.

Functional Magnetic Resonance Imaging in Alzheimer's Disease Drug Trials: A Mini-Review

Alghamdi M, Braidy N.

J Alzheimers Dis. 2024;101(s1):S567-S578. doi: 10.3233/JAD-231276.

The Therapeutic Potential of Yoga for Alzheimer's Disease: A Critical Review

Brown A, Bayley PJ.

J Alzheimers Dis. 2024;101(s1):S521-S535. doi: 10.3233/JAD-240719.

Research Progress of Novel Inorganic Nanomaterials in the Diagnosis and Treatment of Alzheimer's Disease

Ding N, Lei Y, Hu Y, Wei J, Wang W, Zhang R, Cai F.

Neurol India. 2024 Sep 1;72(5):943-950. doi: 10.4103/neurol-india.Neurol-India-D-23-00592. Epub 2024 Oct 19.

Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysis

McLaughlin J, Scotton WJ, Ryan NS, Hardy JA, Shoai M.

Alzheimers Dement. 2024 Dec;20(12):8673-8683. doi: 10.1002/alz.14314. Epub 2024 Oct 22.

Now and future: Strategies for diagnosis, prevention and therapies for Alzheimer's disease

Shi J, Touchon J, Middleton LT, Rovira MB, Vassar R, Vellas B, Shen Y.

Sci Bull (Beijing). 2024 Dec 15;69(23):3777-3784. doi: 10.1016/j.scib.2024.09.042. Epub 2024 Sep 28.

HIV-Associated Neurocognitive Disorder (HAND) and Alzheimer's Disease Pathogenesis: Future Directions for Diagnosis and Treatment

Mustafa M, Musselman D, Jayaweera D, da Fonseca Ferreira A, Marzouka G, Dong C.

Int J Mol Sci. 2024 Oct 17;25(20):11170. doi: 10.3390/ijms252011170.

Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease

García-Alberca JM, De La Guía P, Gris E, Mendoza S, López De La Rica M, López-Trigo JA, López-Mongil R, García-López T, López-García R, Rodríguez Del Rey T, Gay-Puente J, García-Castro J, Casales F, Morato X, Boada M, González-Velasco G, Marín-Carmona JM, Páez NI, León M, Carrillejo R, Rius F, Barbancho MÁ, Lara JP, Blanco-Reina E.

J Alzheimers Dis. 2024 Dec;102(3):866-876. doi: 10.1177/13872877241292018. Epub 2024 Nov 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias